Interventions to improve adherence to antipsychotic medication in patients with schizophrenia-A review of the past decade

European Psychiatry

Volumn 27, Issue 1, 2012, Pages 9-18

  Barkhof, E ^a   Meijer, C J ^a   de Sonneville, L M J ^b   Linszen, D H ^a   de Haan, L ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Adherence; Antipsychotics; Intervention studies; Review of the literature; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ASSERTIVE COMMUNITY TREATMENT; ATTENTION; BEHAVIOR THERAPY; COMPLIANCE THERAPY; ENVIRONMENTAL FACTOR; HUMAN; INTERVIEW; MEMORY; MENTAL PATIENT; METHODOLOGY; MOTIVATIONAL INTERVIEWING; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOPHRENIA; SHORT SURVEY; SOCIAL INTERACTION; SUBSTANCE ABUSE;

ANTIPSYCHOTIC AGENTS; HUMANS; MEDICATION ADHERENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84655162223     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2011.02.005     Document Type: Short Survey

References (115)

1. Agarwal M.R., Sharma V.K., Kishore Kumar K.V., Lowe D. Non-compliance with treatment in patients suffering from schizophrenia: a study to evaluate possible contributing factors. Int J Soc Psychiatry 1998, 44(2):92-106.
2. Atkinson J.M., Coia D.A., Gilmour W.H., et al. The impact of education groups for people with schizophrenia on social functioning and quality of life. Br J Psychiatry 1996, 168:199-204.
3. Azrin N.H., Teichner G. Evaluation of an instructional program for improving medication compliance for chronically mentally ill outpatients. Behav Res Ther 1998, 36:849-861.
4. Battle E.H., Halliburton A., Wallston K.A. Self-medication among psychiatric patients and adherence after discharge. J Psychosoc Nurs Ment Health Serv 1982, 20:21-28.
5. Becker M.H., Maimon L.A. Sociobehavioural determinants of compliance with health and medical care recommendations. Med Care 1975, 13:10-24.
6. Beebe L.H., Smith K., Crye C., et al. Telenursing intervention increases psychiatric medication adherence in schizophrenia outpatients. J Am Psychiatr Nurses Assoc 2008, 14(3):217-224.
7. Bigelow D.A., McFarland B.H., Gareau M.J., Young D.J. Implementation and effectiveness of a bed reduction project. Community Ment Health J 1991, 27:125-133.
8. Boczkowski J.A., Zeichner A., DeSanto N. Neuroleptic compliance among chronic schizophrenic outpatients: an intervention outcome report. J Consult Clin Psychiatry 1985, 53:666-671.
9. Bond G.R., Miller L.D., Krumwied R.D., Ward R.S. Assertive case management in three CMHCs: a controlled study. Hosp Community Psychiatry 1988, 39:411-418.
10. Bond G.R., Witheridge T.F., Wasmer D., et al. A comparison of two crisis housing alternatives to psychiatric hospitalization. Hosp Community Psychiatry 1989, 40:177-183.
11. Bond G.R., McDonel E.C., Miller L.D., Pensec M. Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosoc Rehabil J 1991, 15:30-43.
12. Brown C.S., Wright R.G., Christensen D.B. Association between type of medication instruction and patients' knowledge, side effects, and compliance. Hosp Community Psychiatry 1987, 38:55-60.
13. Buchanan A. A two-year prospective study of treatment compliance in patients with schizophrenia. Psychol Med 1992, 22(3):787-797.
14. Buchkremer G., Klingberg S., Holle R., Schulze Monking H., Hornung W.P. Psychoeducational psychotherapy for schizophrenic patients and their key relatives or caregivers: results of a 2-year follow-up. Acta Psychiatr Scand 1997, 96:483-491.
15. Buckley P.F., Correl C.U. Strategies for dosing and switching antipsychotics for optimal clinical management. J Clin Psychiatry 2008, 67(S1):4-17.
16. Bush C.T., Langford M.W., Rosen P., Gott W. Operation outreach: intensive case management for severely psychiatrically disabled adults. Hosp Community Psychiatry 1990, 41:647-649.
17. Byerly M.J., Thompson A., Carmody T., et al. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr Serv 2007, 58:844-847.
18. Chan S.W., Yip B., Tso S., Cheng B.S., Tam W. Evaluation of a psychoeducation program for Chinese clients with schizophrenia and their family caregivers. Patient Educ Couns 2009, 75(1):67-76.
19. Chien W.T., Chan S.W., Thompson D.R. Effects of a mutual support group for families of Chinese people with schizophrenia: 18-month follow-up. Br J Psychiatry 2006, 189:41-49.
20. Claassen D., Fakhoury W.K., Ford R., Priebe S. Money for medication: financial incentives to improve medication adherence in assertive outreach. Psychiatr Bull 2007, 31:4-7.
21. Connor J., Rafter N., Rodgers A. Do fixed-dose combination pills or unit-of-packaging improve adherence? A systematic review. Bull World Health Organ 2004, 82:935-939.
22. Cramer J.A., Rosenheck R. Compliance with medical regimes for mental and physical disorders. Psychiatr Serv 1998, 49:196-201.
23. De Haan L., Lavalaye J., van Bruggen M., et al. Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications. Can J Psychiatry 2004, 49(5):290-296.
24. Diaz E., Neuse E., Sullivan M.C., Pearsall H.R., Woods S.W. Adherence to conventional and atypical antipsychotics after hospital discharge. J Clin Psychiatry 2004, 65(3):354-360.
25. Dixon L., Weiden P., Torres M., Lehman A. Assertive community treatment and medication compliance in the homeless mentally ill. Am J Psychiatry 1997, 154:1302-1304.
26. Dolder C.R., Lacro J.P., Leckband S., Jeste D.V. Interventions to improve antipsychotic medication adherence: review of recent literature. J Clin Psychopharmacol 2003, 23(4):389-399.
27. Eckman T.A., Liberman R.P., Phipps C.C. Teaching medication management skills to schizophrenic patients. J Clin Psychopharmacol 1990, 10:33-38.
28. Elvevåg B., Maylor E.A., Gilbert A.L. Habitual prospective memory in schizophrenia. BMC Psychiatry 2003, 3:9.
29. Falloon I.R., McGill C.W., Boyd J.L., Pederson J. Family management in the prevention of morbidity of schizophrenia. Arch Gen Psychiatry 1985, 42:887-896.
30. Fenton W.S., Blyler C.R., Heinssen R.K. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull 1997, 23(4):637-651.
31. Ford R., Beadsmore A., Ryan P., Repper J., Craig T., Muijen M. Providing the safety net: case management for people with serious mental illness. J Ment Health 1995, 1:91-97.
32. Frank A.F., Gunderson J.G. The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome. Arch Gen Psychiatry 1990, 47(3):228-236.
33. Gilbert P.L., Harris M.J., McAdams L.A., Jeste D.V. Neuroleptic withdrawal in schizophrenic patients: a review of the literature. Arch Gen Psychiatry 1995, 52(3):173-188.
34. Glick I.D., Clarkin J.F., Haas G.L., Spencer J.H. A randomized clinical trial of inpatient family intervention. VI: mediating variables and outcome. Fam Process 1991, 30:85-99.
35. Gray R. Does patients education enhance compliance with clozapine? A preliminary investigation. J Psychiatr Ment Health Nurs 2000, 7:285-286.
36. Gray R., Wykes T., Edmonds M., Leese M., Gournay K. Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia: cluster randomised controlled trial. Br J Psychiatry. 2004, 185:157-162.
37. Gray R., Leese M., Bindman J., et al. Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial. Br J Psychiatry 2006, 189:508-514.
38. Greenberg R.N. Overview of patient compliance with medication dosing: a literature review. Clin Ther 1984, 6(5):592-599.
39. Giuffrida A., Torgerson D.J. Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ 1997, 315(7110):703-707.
40. Guimon L., Eguiluz I., Bulbena A. Group pharmacotherapy in schizophrenics: attitudinal and clinical changes. Eur J Psychiatry 1993, 7:147-154.
41. Harris N., Lovell K., Day J., Roberts C. An evaluation of a medication management training programme for community mental health professionals; service user level outcomes. A cluster randomised controlled trial. Int J Nurs Stud 2008, 46:645-652.
42. Hayward P., Chan N., Kemp R., et al. Medication self-management: a preliminary report on an intervention to improve medication compliance. J Ment Health 1995, 4:511-517.
43. Herz M.I. Psychosocial treatment. Psychiatr Ann 1996, 26:531-535.
44. Hogarty G.E., Anderson C.M., Reiss D.J., et al. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia, I: one-year effects of a controlled study on relapse and expressed emotion. Arch Gen Psychiatry 1986, 43:633-642.
45. Hogarty G.E., Anderson C.M., Reiss D.J., et al. Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia, II: two-year effects of a controlled study on relapse and adjustment. Arch Gen Psychiatry 1991, 48:340-347.
46. Hogarty G.E., Kornblith S.J., Greenwald D., et al. Three-year trials of personal therapy among schizophrenic patients living with or independent of family. I: description of study and effects on relapse rates. Am J Psychiatry 1997, 154:1504-1513.
47. Hornung W.P., Kieserg A., Feldmann R., Buchkremer G. Psychoeducational training for schizophrenic patients: background, procedure and empirical findings. Patient Educ Couns 1996, 29:257-268.
48. Hornung W.P., Klingberg S., Feldmann R., Schonauer K., Schulze Monking H. Collaboration with drug treatment by schizophrenic patients with and without psychoeducational training: results of a 1-year follow-up. Acta Psychiatr Scand 1998, 97:213-219.
49. Hudson T.J., Owen R.R., Thrush C.R., et al. Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia. J Clin Psychiatry 2008, 69:74-80.
50. Jeste S.D., Patterson T.L., Palmer B.W., Dolder C.R., Goldman S., Jeste D.V. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr Res 2003, 63(1-2):49-58.
51. Kashner T.M., Rader L.E., Rodell D.E., Beck C.M., Rodell L.R., Muller K. Family characteristics, substance abuse, and hospitalization patterns of patients with schizophrenia. Hosp Community Psychiatry 1991, 42:195-197.
52. Kelly G.R., Scott J.A. Medication compliance and health education among outpatients with chronic mental disorders. Med Care 1990, 28:1181-1197.
53. Kemp R., Hayward P., Applewhaite G., Everitt B., David A. Compliance therapy in psychotic patients: randomised controlled trial. BMJ 1996, 312(10):345-349.
54. Kemp R., Kirov G., Everitt B., Hayward P., David A. Randomised controlled trial of compliance therapy: 18-month follow-up. Br J Psychiatry 1998, 172:413-419.
55. Klingberg S., Schneider S., Wittorf A., Buchkremer G., Wiedemann G. Collaboration in outpatient antipsychotic drug treatment: analysis of potentially influencing factors. Psychiatry Res 2008, 161(2):225-234.
56. Lacro J.P., Dunn L.B., Dolder C.R., Leckband S.G., Jeste D.V. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002, 63(10):892-909.
57. Leff J., Kuipers L., Berkowitz R., Sturgeon D. A controlled trial of social interventions in the families of schizophrenia patients: two-year follow-up. Br J Psychiatry 1985, 146:594-600.
58. Leff J., Berkowitz R., Shavit N., Strachan A., Glass I., Vaughn C. A trial of family therapy versus a relatives group for schizophrenia. Br J Psychiatry 1989, 154:58-66.
59. Leff J., Berkowitz R., Shavit N., Strachan A., Glass I., Vaughn C. A trial of family therapy versus a relatives group for schizophrenia: two-year follow-up. Br J Psychiatry 1990, 157:571-577.
60. Lehman A.F., Kreyenbuhl J., Buchanan R.W., et al. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003. Schizophr Bull 2004, 30(2):193-217.
61. Leucht S., Barnes T.R., Kissling W., Engel R.R., Correll C., Kane J.M. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials. Am J Psychiatry 2003, 160(7):1209-1222.
62. Leucht S., Heres S. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. J Clin Psychiatry 2006, 67(S5):3-8.
63. Li Z., Arthur D. Family education for people with schizophrenia in Beijing, China. Br J Psychiatry 2005, 187:339-345.
64. Lindenmayer J.P., Liu-Seifert H., Kulkarni P.M., et al. Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with sub-optimal prior response. J Clin Psychiatry 2009, 70(7):990-996.
65. Linszen D., Dingemans P., Van Der Does J.W., et al. Treatment, expressed emotion, and relapse in recent onset schizophrenic disorders. Psychol Med 1996, 26:333-342.
66. McEvoy J.P., Freter S., Everett G., et al. Insight and the clinical outcome of schizophrenic patients. J Nerv Ment Dis 1989, 177(1):48-51.
67. McFarlane W.R., Lukens E., Link B., et al. Multiple-family groups and psychoeducation in the treatment of schizophrenia. Arch Gen Psychiatry 1995, 52:679-687.
68. Macpherson R., Jerrom B., Hughes A. A controlled study of education about drug treatment in schizophrenia. Br J Psychiatry 1996, 168:709-717.
69. Malm U. The influence of group therapy on schizophrenia. Acta Psychiatr Scand 1982, 297(Suppl.):1-65.
70. Maneesakorn S., Robson D., Gournay K., et al. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand. J Clin Nurs 2007, 16:1302-1312.
71. Merinder L.B., Viuff A.G., Laugesen H.D., Clemmensen K., Misfelt S., Espensen B. Patient and relative education in community psychiatry: a randomized controlled trial regarding its effectiveness. Soc Psychiatry Psychiatr Epidemiol 1999, 34:287-294.
72. Miller W.R., Rollnick S. Motivational interviewing: preparing people for change 2002, Guilford Press, New York.
73. Modrcin M., Rapp C.A., Poertner J. The evaluation of case management services with the chronically mentally ill. Eval Program Plann 1988, 11:307-314.
74. Möller H.J. Clinical evaluation of negative symptoms in schizophrenia. Eur Psychiatry 2007, 22:380-386.
75. Morken G., Grawe R.W., Widen J.H. Effects of an integrated treatment on antipsychotic medication adherence in a randomized trial in recent-onset schizophrenia. J Clin Psychiatry 2007, 68(4):566-571.
76. Newcomer J.W., Haupt D.W. The metabolic effects of antipsychotic medications. Can J Psych 2006, 51:480-491.
77. O'Donnell C., Donohoe G., Sharkey L., et al. Compliance therapy: a randoimised cotrolled trail in schizophrenia. BMJ 2003, 327(7419):834.
78. Perkins D.O. Adherence to antipsychotic medications. J Clin Psychiatry 1999, 60(Suppl.21):25-30.
79. Petersen L., Jeppesen P., Thorup A., Abel M.B., Øhlenschlaeger J., et al. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ 2005, 331(7517):602.
80. Pijnenborg GH, Withaar FK, Brouwer WH, Timmerman ME, van den Bosch RJ, Evans JJ. The efficacy of SMS text messages to compensate for the effects of cognitive impairments in schizophrenia. Br J Clin Psychol 2009 [Epub].
81. Priebe S., Burton A., Ashby D., et al. Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT). BMC Psychiatry 2009, 9:61.
82. Ran M.S., Xiang M.Z., Chan C.L., et al. Effectiveness of psychoeducational intervention for rural Chinese families experiencing schizophrenia-a randomised controlled trial. Soc Psychiatry Psychiatr Epidemiol 2003, 38(2):69-75.
83. Razali M.S., Yahya H. Compliance with treatment in schizophrenia: a drug intervention program in a developing country. Acta Psychiatr Scand 1995, 91:331-335.
84. Razali S.M., Hasanah C.I., Khan A., Subramaniam M. Psychosocial interventions for schizophrenia. J Ment Health 2000, 9:283-289.
85. Remington G.J., Adams M.E. Depot neuroleptic therapy: clinical considerations. Can J Psychiatry 1995, 40(3 Suppl.1):S5-S11.
86. Robinson D., Woerner M., Alvir J., et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999, 56:241-247.
87. Robinson D.G., Woerner M.G., Alvir J.M., Bilder R.M., Hinrichsen G.A., Lieberman J.A. Predictors of medication discontinuation by patients with first episode schizophrenia and schizoaffective disorder. Schizophr Res 2002, 57:209-219.
88. Sands R.G., Cnaan R.A. Two models of case management: assessing their impact. Community Ment Health J 1994, 30:441-457.
89. Schooler N.R., Keith S.J., Severe J.B., et al. Relapse and rehospitalization during maintenance treatment of schizophrenia: the effects of dose reduction and family treatment. Arch Gen Psychiatry 1997, 54:453-463.
90. Schooler N.R. Relapse and rehospitalization: comparing oral and depot antipsychotics. J Clin Psychiatry 2003, 64(Suppl.16):14-17.
91. Seltzer A., Roncar I., Garfinkel P. Effect of patient education on medication compliance. Can J Psychiatry 1980, 25:638-645.
92. Solomon P., Draine J. The efficacy of a consumer case management team: 2-year outcomes of a randomized trial. J Ment Health Adm 1995, 22:135-146.
93. Spaniel F., Vohlídka P., Hrdlicka J., et al. ITAREPS: information technology aided relapse prevention programme in schizophrenia. Schizophr Res 2008, 98:312-317.
94. Stein L.I., Test M.A. Alternative to mental hospital treatment. I: conceptual model, treatment program, and clinical evaluation. Arch Gen Psychiatry 1980, 37:392-397.
95. Strang J.S., Falloon I.R., Moss H.B., Razani J., Boyd J.L. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacol Bull 1981, 17:87-88.
96. Streicker S.K., Amdur M., Dincin J. Educating patients about psychiatric medications: failure to enhance compliance. Psychosoc Rehabil J 1986, 4:15-28.
97. Tarrier N. The community management of schizophrenia: a controlled trial of a behavioural intervention with families to reduce relapse. Br J Psychiatry 1988, 153:532-542.
98. Telles C., Karno M., Mintz J., et al. Immigrant families coping with schizophrenia: behavioural family intervention v case management with a low-income Spanish-speaking population. Br J Psychiatry 1995, 167:473-479.
99. Turner E.H., Matthews A.M., Eftihia Linardatos E., et al. Selective publication of antidepressant trials and its onfluence on apparent Efficay. N Eng J Med 2008, 358:252-260.
100. Uzenoff S.R., Perkins D.O., Hamer R.M., Wiesen C.A., Penn D.L. A preliminary trial of adherence-coping-education (ACE) therapy for early psychosis. J Nerv Ment Dis 2008, 196:572-575.
101. Valenstein M, Kavanagh J, Lee T, et al. Using a pharmacy-based intervention to improve antispychotic adherence among patients with serious mental illness. Schizophr Bull 2009 [Epub Nov 21:1-10].
102. Van Putten P. Why do schizophrenic patients refuse to take their drugs?. Arch Gen Psychiatry 1974, 31:67-72.
103. Van Putten T., Crumpton E., Yale C. Drug refusal in schizophrenia and the wish to be crazy. Arch Gen Psychiatry 1976, 33(12):1443-1446.
104. Velligan D.I., Lam Y.W., Glahn D.C., et al. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull 2006, 32:724-742.
105. Velligan D.I., Wang M., Diamond P., et al. Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr Serv 2007, 58(9):1187-1192.
106. Velligan D.I., Diamond P.M., Mintz J., et al. The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophr Bull 2008, 34(3):483-493.
107. Velligan D.I., Weiden P.J., Sajatovic M., et al. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry 2009, 70(Suppl.4):1-46.
108. Weiden P.J., Shaw E., Mann J. Causes of neuroleptic noncompliance. Psychiatr Ann 1986, 16:571-575.
109. Weiden P.I., Olfson M. Cost of relapse in schizophrenia. Schizophr Bull 1995, 21:419-429.
110. Weiden P.J., Kozma C., Grogg A., Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. J Psychiatr Serv 2004, 55(8):886-891.
111. Xiang M., Ran M., Li S. A controlled evaluation of psychoeducational family intervention in a rural Chinese community. Br J Psychiatry 1994, 165:544-548.
112. Xiong W., Phillips M.R., Xiong H., et al. Family-based intervention for schizophrenic patients in China: a randomised controlled trial. Br J Psychiatry 1994, 165:239-247.
113. Young J.L., Zonana H.V., Shepler L. Medication noncompliance in schizophrenia: codification and update. Bull Am Acad Psychiatry Law 1986, 14:105-122.
114. Zhang M., Wang M., Li J., Phillips M.R. Randomised-control trial of family intervention for 78 first-episode male schizophrenic patients: an 18-month study in Suzhou, Jiangsu. Br J Psychiatry Suppl 1994, 24:96-102.
115. Zygmunt A., Olfson M., Boyer C.A., Mechanic D. Interventions to improve medication adherence in schizophrenia. Am J Psychiatry 2002, 159(10):1653-1664.